Gururangan, S., Reap, E., Reynolds, R., Grant, G., Onar-Thomas, A., Kodak, M., … Mitchell, D. (2016). IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11). In NEURO-ONCOLOGY (Vol. 18, pp. 118–118).

Gururangan, Sridharan, Elizabeth Reap, Renee Reynolds, Gerald Grant, Arzu Onar-Thomas, Mehmet Kodak, Patricia Baxter, et al. “IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11).” In NEURO-ONCOLOGY, 18:118–118, 2016.

Gururangan S, Reap E, Reynolds R, Grant G, Onar-Thomas A, Kodak M, et al. IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11). In: NEURO-ONCOLOGY. 2016. p. 118–118.

Gururangan, Sridharan, et al. “IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11).” NEURO-ONCOLOGY, vol. 18, 2016, pp. 118–118.

Gururangan S, Reap E, Reynolds R, Grant G, Onar-Thomas A, Kodak M, Baxter P, Pollack I, Phillips P, Boyett J, Fouladi M, Mitchell D. IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11). NEURO-ONCOLOGY. 2016. p. 118–118.